Addex Therapeutics (ADXN) Receivables - Net (2018 - 2026)
Addex Therapeutics' Receivables - Net was $37,636 in Q2 2026, down 18.9% from $46,430 a year earlier and down 7.9% from the prior quarter.
Powered by 
Analysis
Addex Therapeutics (ADXN) Receivables - Net (2018 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Addex Therapeutics came in at $25,132, up 42.5% from FY2024.
- Receivables - Net shows a five-year compound annual growth rate of -19.8% (FY2020 to FY2025).
- In earlier years, Receivables - Net was $17,634 in FY2024 (-85.8%), $124,416 in FY2023 (-100.0%), $432.73 billion in FY2022 and $178,710 in FY2021 (+136.3%).
- Quarterly Receivables - Net has moved between $17,708 (Q4 2024) and $432.73 billion (Q4 2022) over five years.
- Compared with a year earlier, Receivables - Net was higher in three of the last eight quarters, with an average decline of 18.1%.
- The best year-over-year quarter for Receivables - Net over five years was Q1 2022 (growth of 390.9%); the worst was Q4 2023 (a decline of 100.0%).
- Per Business Quant data, ADXN's Receivables - Net in the three quarters before Q2 2026 was $40,854 (Q1 2026), $25,132 (Q4 2025) and $64,064 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Addex Therapeutics | 5.10 Mn | -1.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36,832.59 |
| Mar 31, 2026 | 39,996.00 |
| Dec 31, 2025 | 25,371.98 |
| Sep 30, 2025 | 64,283.74 |
| Jun 30, 2025 | 48,154.09 |
| Mar 31, 2025 | 40,144.18 |
| Dec 31, 2024 | 17,174.84 |
| Sep 30, 2024 | 571,095.76 |
| Jun 30, 2024 | 652,081.19 |
| Mar 31, 2024 | 129,008.84 |
| Dec 31, 2023 | 130,858.70 |
| Sep 30, 2023 | 201,436.44 |
| Jun 30, 2023 | 284,333.90 |
| Mar 31, 2023 | 252,264.12 |
| Dec 31, 2022 | 451,725.62 |
| Sep 30, 2022 | 305,325.50 |
| Jun 30, 2022 | 347,701.68 |
| Mar 31, 2022 | 397,439.77 |
| Dec 31, 2021 | 180,349.14 |
| Sep 30, 2021 | 213,042.56 |
API Access
Addex Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ADXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ADXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ADXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();